A weight loss drug developer's stock soars after a $198 million IPOByBruce GilPublishedSeptember 26, 2024
The Boar's Head listeria outbreak has been linked to a 10th death. Lawmakers want answersByBruce GilPublishedSeptember 26, 2024
Disney+ is following Netflix in cracking down on password sharingByBruce GilUpdatedSeptember 26, 2024
Now playing BioAge Labs wants to raise $200 million in IPO to develop obesity and diabetes drugsPublishedSeptember 25, 2024
Novo Nordisk's CEO took the Washington hot seat over Ozempic prices. 3 takeaways from his testimonyByBruce GilPublishedSeptember 24, 2024
Blame drug 'middlemen' for Ozempic and Wegovy prices, Novo Nordisk CEO tells CongressByBruce GilUpdatedSeptember 24, 2024
Novo Nordisk is bigger than Denmark's economy — but the prime minister isn't worried about another NokiaByBruce GilUpdatedSeptember 23, 2024
Novo Nordisk's experimental weight loss pill has some concerning side effectsByBruce GilUpdatedSeptember 20, 2024
Bridgerton, Berlin, and more: The 10 most-watched shows on Netflix so far this yearByBruce GilPublishedSeptember 20, 2024
People watched a whopping 94 billion hours of Netflix in the first half of 2024, CEO saysByBruce GilPublishedSeptember 18, 2024
The studio behind Twilight and The Hunger Games just turned over its media library for AIByBruce GilPublishedSeptember 18, 2024
Bernie Sanders says drugmakers could sell generic Ozempic for less than $100ByBruce GilPublishedSeptember 17, 2024
Ozempic will likely get cheaper for millions on Medicare, Novo Nordisk exec saysByBruce GilUpdatedSeptember 17, 2024
The FTC is being sued by Express Scripts over a 'defamatory' report on drug pricesByBruce GilUpdatedSeptember 17, 2024
Failing to properly represent Latinos costs Hollywood billions every year. Here's howByBruce GilUpdatedSeptember 16, 2024
Off-brand Ozempic, Roche stock woes, and Eli Lilly's weekly insulin: Pharma news round upByBruce GilPublishedSeptember 13, 2024
